| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |